Australia markets close in 1 hour 40 minutes

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
11.03-0.17 (-1.52%)
At close: 04:00PM EDT
11.00 -0.03 (-0.27%)
After hours: 07:58PM EDT

Teva Pharmaceutical Industries Limited

124 Dvora Hanevi’a Street
Tel Aviv 6944020
Israel
972 3 914 8213
https://www.tevapharm.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full-time employees34,713

Key executives

NameTitlePayExercisedYear born
Mr. Kare SchultzPres, CEO & Director4.68MN/A1961
Mr. Eliyahu Sharon KalifExec. VP & CFO1.74MN/A1973
Mr. Eric DrapeExec. VP of Global Operations1.91MN/A1962
Mr. Mark SabagExec. VP of International Markets Commercial1.79MN/A1971
Dr. Sven Dethlefs Ph.D.Exec. VP of North America Commercial1.72MN/A1969
Mr. Amir WeissSr. VP & Chief Accounting OfficerN/AN/A1977
Mr. Kevin C. MannixSr. VP of Investor RelationsN/AN/AN/A
Mr. David M. StarkExec. VP & Chief Legal OfficerN/AN/A1969
Ms. Lori QueisserSr. VP & Global Compliance OfficerN/AN/AN/A
Mr. Eli ShaniExec. VP of Global Marketing & PortfolioN/AN/AN/A
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.

Corporate governance

Teva Pharmaceutical Industries Limited’s ISS governance QualityScore as of 31 July 2022 is 4. The pillar scores are Audit: 2; Board: 4; Shareholder rights: 3; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.